First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib

Title
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 3, Issue 1, Pages 47
Publisher
Springer Nature
Online
2010-11-27
DOI
10.1186/1756-8722-3-47

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now